Strive Financial Group »

Northwest Biotherapeutics In shares owned by Strive Financial Group

Quarter-by-quarter ownership of Northwest Biotherapeutics In (NWBO) shares owned by Strive Financial Group from 13F filings

Historical chart of Strive Financial Group investment in Northwest Biotherapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Northwest Biotherapeutics In held by Strive Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Northwest Biotherapeutics In by Strive Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $19 100 0.19

More positions owned by Strive Financial Group

Vanguard S&p 500 Etf Uit Exchange Traded (VOO)
Ishares Core Msci Eafe Etf Uit Exchange Traded (IEFA)
Zacks Earnings Consistent Portfolio Etf Uit Exchange Traded (ZECP)
Zacks Focus Growth Etf Uit Exchange Traded (GROZ)
Alphabet Inc Class C Common Stock (GOOG)
Zacks Small/mid Cap Etf Uit Exchange Traded (SMIZ)
Vanguard Mid-cap Index Fund Etf Shares Uit Exchange Traded (VO)
Nvidia Corp Common Stock (NVDA)
Alphabet Inc Class A Common Stock (GOOGL)
Eli Lilly And Common Stock (LLY)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc Class A Common Stock (META)
Ishares Core U.s. Aggregate Bond Etf Uit Exchange Traded (AGG)
Ishares Russell 1000 Growth Etf Uit Exchange Traded (IWF)

View all positions for Strive Financial Group

Top funds holding Northwest Biotherapeutics In

Wall Street Access Asset Management
VSM Wealth Advisory
Opus Capital Group
Ethos Financial Group
Williams Jones Wealth Management
Coston, McIsaac & Partners
McIlrath & Eck
Hantz Financial Services
Strive Financial Group

View all funds holding Northwest Biotherapeutics In